Skip to main content
VulnerabilityPublished Updated

CVE-2026-54215: Tobit Laboratories AG TeamDavid's Webbox contains an open redirect vulnerability via the “replyUrl”

Source GCVE Database

0
Authoritative record:CVE-2026-54215· Medium 5.3

Not known to be exploited · CVSS 5.3 Medium : upgrade to Rollout 528 when convenient.

Data as of 26 Oct 2026, 13:47 UTC

CVSS 4.0 base score
5.3Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.4% chance of exploitation in 30 days – higher than 39% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in Rollout 528
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 7 Aug 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Upgrade TeamDavid to Rollout 528.

Affected software

ProductAffectedFixed in
Tobit Laboratories AGTeamDavidAffected
  • =0
Fixed in
  • Rollout 528

Description

Tobit Laboratories AG TeamDavid's Webbox contains an open redirect vulnerability via the “replyUrl” parameter. An attacker can exploit this vulnerability to craft a URL within the application that, when visited, redirects the user’s browser to an arbitrary third-party site. This can be abused for phishing attacks, where users receive a trusted domain link but are redirected to a phishing website. This issue affects TeamDavid through Rollout 524.

References

Community reviews

Loading reviews…